HealthEquity Gross Profit from 2010 to 2025

HQY Stock

USD 84.88 0.28 0.33%

HealthEquity Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit HealthEquity makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2012-04-30

Previous Quarter

197 M

Current Value

189 M

Quarterly Volatility

57.7 M

Yuan Drop

Covid

Check HealthEquity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HealthEquity's main balance sheet or income statement drivers, such as Depreciation And Amortization of 170.6 M, Interest Expense of 63.7 M or Selling General Administrative of 138.9 M, as well as many indicators such as Price To Sales Ratio of 6.55, Dividend Yield of 0.0735 or PTB Ratio of 5.59. HealthEquity financial statements analysis is a perfect complement when working with HealthEquity Valuation or Volatility modules.

Check out the analysis of HealthEquity Correlation against competitors.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Latest HealthEquity's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of HealthEquity over the last few years. Gross profit is a required income statement account that reflects total revenue of HealthEquity minus its cost of goods sold. It is profit before HealthEquity operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. HealthEquity's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HealthEquity's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 777.26 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

HealthEquity Gross Profit Regression Statistics

	Arithmetic Mean	282,453,434
	Geometric Mean	146,751,219
	Coefficient Of Variation	98.14
	Mean Deviation	236,735,489
	Median	181,193,000
	Standard Deviation	277,195,130
	Sample Variance	76837.1T
	Range	792M
	R-Value	0.95
	Mean Square Error	8787.1T
	R-Squared	0.89
	Slope	55,027,756
	Total Sum of Squares	1152557.1T

HealthEquity Gross Profit History

	2025	816.1 M
	2024	777.3 M
	2023	622.6 M
	2022	490.1 M
	2021	423.7 M
	2020	415.3 M
	2019	325.9 M

Other Fundumenentals of HealthEquity

Gross Profit Margin

HealthEquity Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Accounts Payable	Good Will	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Net Debt	Retained Earnings	Net Receivables	Total Current Assets	Net Tangible Assets	Capital Surpluse	Net Invested Capital	Long Term Investments	Net Working Capital	Capital Stock	Long Term Debt Total	Short Long Term Debt	Short Term Debt	Current Deferred Revenue
Total Assets		0.98	0.71	1.0	0.91	0.92	0.99	0.79	0.92	0.54	0.85	0.95	0.82	-0.91	0.99	0.98	-0.57	0.22	0.92	-0.51	-0.56	-0.53	0.5
Total Stockholder Equity	0.98		0.75	0.98	0.9	0.85	0.97	0.81	0.9	0.42	0.82	0.94	0.84	-0.83	0.98	0.96	-0.6	0.34	0.94	-0.55	-0.64	-0.62	0.54
Accounts Payable	0.71	0.75		0.71	0.61	0.64	0.7	0.61	0.63	0.41	0.56	0.75	0.56	-0.6	0.69	0.74	-0.23	0.1	0.67	-0.18	-0.86	-0.58	0.29
Good Will	1.0	0.98	0.71		0.89	0.91	0.99	0.75	0.91	0.53	0.8	0.93	0.77	-0.92	0.99	0.98	-0.59	0.2	0.93	-0.53	-0.58	-0.55	0.53
Short Term Investments	0.91	0.9	0.61	0.89		0.84	0.89	0.8	0.83	0.44	0.94	0.87	0.89	-0.78	0.9	0.88	-0.52	0.33	0.81	-0.45	-0.44	-0.43	0.45
Total Liab	0.92	0.85	0.64	0.91	0.84		0.89	0.75	0.86	0.76	0.86	0.93	0.76	-0.97	0.89	0.95	-0.27	0.01	0.82	-0.21	-0.4	-0.28	0.33
Intangible Assets	0.99	0.97	0.7	0.99	0.89	0.89		0.76	0.9	0.47	0.8	0.92	0.76	-0.89	0.99	0.96	-0.65	0.18	0.93	-0.6	-0.57	-0.57	0.59
Common Stock	0.79	0.81	0.61	0.75	0.8	0.75	0.76		0.73	0.35	0.86	0.85	0.92	-0.65	0.77	0.79	-0.33	0.3	0.76	-0.28	-0.43	-0.39	0.42
Property Plant Equipment	0.92	0.9	0.63	0.91	0.83	0.86	0.9	0.73		0.52	0.8	0.86	0.79	-0.82	0.95	0.91	-0.47	0.2	0.86	-0.42	-0.33	-0.27	0.41
Net Debt	0.54	0.42	0.41	0.53	0.44	0.76	0.47	0.35	0.52		0.52	0.55	0.36	-0.79	0.49	0.6	0.26	-0.34	0.3	0.31	-0.12	0.14	-0.32
Retained Earnings	0.85	0.82	0.56	0.8	0.94	0.86	0.8	0.86	0.8	0.52		0.88	0.94	-0.76	0.82	0.84	-0.3	0.28	0.75	-0.23	-0.32	-0.27	0.33
Net Receivables	0.95	0.94	0.75	0.93	0.87	0.93	0.92	0.85	0.86	0.55	0.88		0.87	-0.86	0.93	0.98	-0.37	0.29	0.93	-0.3	-0.6	-0.51	0.47
Total Current Assets	0.82	0.84	0.56	0.77	0.89	0.76	0.76	0.92	0.79	0.36	0.94	0.87		-0.64	0.81	0.81	-0.33	0.51	0.79	-0.26	-0.38	-0.37	0.36
Net Tangible Assets	-0.91	-0.83	-0.6	-0.92	-0.78	-0.97	-0.89	-0.65	-0.82	-0.79	-0.76	-0.86	-0.64		-0.88	-0.93	0.34	0.07	-0.78	0.29	0.41	0.32	-0.3
Capital Surpluse	0.99	0.98	0.69	0.99	0.9	0.89	0.99	0.77	0.95	0.49	0.82	0.93	0.81	-0.88		0.97	-0.6	0.25	0.94	-0.54	-0.53	-0.51	0.54
Net Invested Capital	0.98	0.96	0.74	0.98	0.88	0.95	0.96	0.79	0.91	0.6	0.84	0.98	0.81	-0.93	0.97		-0.45	0.21	0.93	-0.39	-0.58	-0.5	0.47
Long Term Investments	-0.57	-0.6	-0.23	-0.59	-0.52	-0.27	-0.65	-0.33	-0.47	0.26	-0.3	-0.37	-0.33	0.34	-0.6	-0.45		-0.27	-0.61	1.0	0.34	0.62	-0.81
Net Working Capital	0.22	0.34	0.1	0.2	0.33	0.01	0.18	0.3	0.2	-0.34	0.28	0.29	0.51	0.07	0.25	0.21	-0.27		0.4	-0.25	-0.26	-0.5	0.28
Capital Stock	0.92	0.94	0.67	0.93	0.81	0.82	0.93	0.76	0.86	0.3	0.75	0.93	0.79	-0.78	0.94	0.93	-0.61	0.4		-0.56	-0.59	-0.63	0.71
Long Term Debt Total	-0.51	-0.55	-0.18	-0.53	-0.45	-0.21	-0.6	-0.28	-0.42	0.31	-0.23	-0.3	-0.26	0.29	-0.54	-0.39	1.0	-0.25	-0.56		0.31	0.61	-0.8
Short Long Term Debt	-0.56	-0.64	-0.86	-0.58	-0.44	-0.4	-0.57	-0.43	-0.33	-0.12	-0.32	-0.6	-0.38	0.41	-0.53	-0.58	0.34	-0.26	-0.59	0.31		0.86	-0.4
Short Term Debt	-0.53	-0.62	-0.58	-0.55	-0.43	-0.28	-0.57	-0.39	-0.27	0.14	-0.27	-0.51	-0.37	0.32	-0.51	-0.5	0.62	-0.5	-0.63	0.61	0.86		-0.62
Current Deferred Revenue	0.5	0.54	0.29	0.53	0.45	0.33	0.59	0.42	0.41	-0.32	0.33	0.47	0.36	-0.3	0.54	0.47	-0.81	0.28	0.71	-0.8	-0.4	-0.62

Click cells to compare fundamentals

About HealthEquity Financial Statements

HealthEquity investors use historical fundamental indicators, such as HealthEquity's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in HealthEquity. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	777.3 M	816.1 M
Gross Profit Margin	0.65	0.46

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC